Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Once again, federal funding restrictions cast uncertainty over the field.
Replacing certain cells in the retina could slow visual impairment for people with macular degeneration.
An alternative way to make stem cells could open a window on human disease.
Scientists get ready for the end of federal restrictions on embryonic-stem-cell research.
The findings cast doubt on a promising alternative to the use of embryonic stem cells in medicine.
A small biotech firm is the second company to start human tests of embryonic stem-cell therapy.
Some scientists are reluctant to enter the field, and some consider leaving it altogether, because of the uncertainty of government regulations.
Human embryonic stem cells can be coaxed into three-dimensional structures of retinal cells.
Stem cells from human testes could be used for personalized medicine.